Cargando…
Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?
Since the golden age of antibiotics in the 1950s and 1960s actinomycetes have been the most prolific source for bioactive natural products. However, the number of discoveries of new bioactive compounds decreases since decades. New procedures (e.g., activating strategies or innovative fermentation te...
Autor principal: | Krause, Janina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471533/ https://www.ncbi.nlm.nih.gov/pubmed/34576921 http://dx.doi.org/10.3390/molecules26185450 |
Ejemplares similares
-
Integrated
Metabolomic–Genomic Workflows Accelerate
Microbial Natural Product Discovery
por: Avalon, Nicole E., et al.
Publicado: (2022) -
Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in China
por: Hong, Kui, et al.
Publicado: (2009) -
Non-streptomycete actinomycetes nourish the current microbial antibiotic drug discovery
por: Jose, Polpass Arul, et al.
Publicado: (2013) -
Biodiversity, Anti-Trypanosomal Activity Screening, and Metabolomic Profiling of Actinomycetes Isolated from Mediterranean Sponges
por: Cheng, Cheng, et al.
Publicado: (2015) -
Bioassay- and metabolomics-guided screening of bioactive soil actinomycetes from the ancient city of Ihnasia, Egypt
por: Sebak, Mohamed, et al.
Publicado: (2019)